FDA Clears 900-Unit Insulin Glargine Pen

March 27, 2018. The US Food and Drug Administration has cleared Sanofi’s new 900-unit insulin glargine pen, the Max SoloStar. With a higher capacity than any other long-acting insulin pen on the market, the Max SoloStar pen provides up to 160 units/mL of insulin glargine in a single injection. This means fewer injections, refills, and related copays for some patients, which could ease both the injection and financial burden of living with diabetes. Read the announcement here.